Literature DB >> 143386

Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.

A A Rossini, M C Appel, R M Williams, A A Like.   

Abstract

Multiple injections of subdiabetogenic doses of streptozotocin (SZ) to CD-1 male mice produce a diabetic syndrome that includes a cell-mediated immune reaction against the pancreatic islet. The importance of the host genetic background in the pathogenesis of this model of diabetes was studied by comparing various inbred strains of mice. Of eight strains of mice studied, only C57BL/KsJ developed insulitis and hyperglycemia comparable to that observed in CD-1 mice. In two mouse strains (DBA/J and BALB/cJ) having an H-2d haplotype similar to the C57BL/KsJ, only mild insulitis and glucose intolerance were observed. These data suggest that major histocompatibility complex genes, as presently defined, cannot be the only determinant of the severity of hyperglycemia and insulitis in this model.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 143386     DOI: 10.2337/diab.26.10.916

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  41 in total

1.  A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice.

Authors:  K Kaku; J McGill; M Province; M A Permutt
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

2.  Connexins protect mouse pancreatic β cells against apoptosis.

Authors:  Philippe Klee; Florent Allagnat; Helena Pontes; Manon Cederroth; Anne Charollais; Dorothée Caille; Aurore Britan; Jacques-Antoine Haefliger; Paolo Meda
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

3.  The influence of genetic background on the susceptibility of mice to diabetes induced by alloxan and on recovery from alloxan diabetes.

Authors:  J A Cohn; A Cerami
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

4.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

5.  Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits.

Authors:  E H Leiter; P H Le; D L Coleman
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice.

Authors:  T Linn; E Loewk; K Schneider; K Federlin
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

7.  Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.

Authors:  R C McEvoy; J Andersson; S Sandler; C Hellerström
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice.

Authors:  Richard C Davis; Lawrence W Castellani; Maryam Hosseini; Osnat Ben-Zeev; Hui Z Mao; Michael M Weinstein; Dae Young Jung; John Y Jun; Jason K Kim; Aldons J Lusis; Miklós Péterfy
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

9.  The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro.

Authors:  S Sandler; A Andersson
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

10.  Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.

Authors:  S J Zunino; L F Simons; J F Sambrook; M J Gething
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.